ArticleNeurology and clinical neuroscience2022
Myelin-oligodendrocyte glycoprotein antibody-associated optic neuritis following SARS-CoV-2 pneumonia: A case report.
Article in Neurology and clinical neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.
- Systematic review exploring the clinical features of optic neuritis after SARS-CoV infection and vaccination.BMJ open ophthalmology · 2023Pooled it
- Plasmapheresis in post-COVID-19 myelitis: A case report.Qatar medical journal · 2024Article
- Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a post-COVID-19 infection patient.Immunity, inflammation and disease · 2023Article
- Myelin-oligodendrocyte glycoprotein antibody-associated optic neuritis following SARS-CoV-2 pneumonia: A case report.Neurology and clinical neuroscience · 2022Article
- COVID-19 - a potential trigger for MOGAD-associated optic neuritis: a case report and literature review.Therapeutic advances in ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a case of a 60-year-old man with optic neuritis following severe acute respiratory syndrome coronavirus 2 pneumonia. He tested positive for serum myelin-oligodendrocyte glycoprotein IgG antibody and was treated with intravenous methylprednisolone (1 g/d) for 5 days followed by oral prednisolone taper. Six weeks after treatment, his symptoms resolved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.